Who Paid My Doc
Vanacof
Drug Cough and Cold
NDC 58809-999-01
General payments
$60,461
Research payments
$0
Through program year 2025, $60,461 in general payments and $0 in research payments were reported against Vanacof (Cough and Cold).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $4,460 | 54 |
| 2024 | General | $1,381 | 8 |
| 2023 | General | $11,169 | 59 |
| 2022 | General | $31,435 | 47 |
| 2021 | General | $369 | 2 |
| 2020 | General | $4,871 | 15 |
| 2019 | General | $6,777 | 4 |
Breakdown
The top 5 of 54 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
189 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.